Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2001

Content (14 Articles)

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Per E. Lønning, Paul D. Taylor, Gun Anker, Julie Iddon, Liv Wie, Linn-Marie Jørgensen, Olav Mella, Anthony Howell

The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography

Irma Saarenmaa, Tiina Salminen, Ulla Geiger, Pirkko Heikkinen, Seppo Hyvärinen, Jorma Isola, Vesa Kataja, Marja-Liisa Kokko, Riitta Kokko, Eero Kumpulainen, Alpo Kärkkäinen, Juhani Pakkanen, Pirkko Peltonen, Anneli Piironen, Anja Salo, Marja-Liisa Talviala, Matti Hakama

Impact of the axillary nodal status on sentinel node mapping in breast cancer and its relevance for technical proceeding

Thomas Heuser, Thomas Rink, Esra Weller, Hartmut Fitz, Hans-Herbert Zippel, Rolf Kreienberg, Thorsten Kühn

Suppression of aromatase (estrogen synthetase) by red wine phytochemicals

Elizabeth T. Eng, Dudley Williams, Usha Mandava, Nimeer Kirma, Rajeshwar Rao Tekmal, Shiuan Chen

Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens

Andrea Manni, Stephanie H. Astrow, Susan Gammon, James Thompson, David Mauger, Sharlene Washington

1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects

Qin Wang, Dawn Lee, Vilayvanh Sysounthone, Roshantha A.S. Chandraratna, Sylvia Christakos, Reju Korah, Robert Wieder

Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer

Masaru Ooka, Yasuhiro Tamaki, Isao Sakita, Yoshiyuki Fujiwara, Hirofumi Yamamoto, Yasuhiro Miyake, Mitsugu Sekimoto, Masayuki Ohue, Yurika Sugita, Yasuo Miyoshi, Noriko Ikeda, Shinzaburo Noguchi, Morito Monden

BRCA1 and BRCA2: to test or not to test

Rachael T. Brandt, Henry T. Lynch

Letter to the Editor

Letter to the editor

Giovanni Corrao

Corrigendum

Corrigendum

Instructions for Authors

Breast Cancer Research and Treatment

Michele Alexander

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine